Financhill
Buy
78

JLL Quote, Financials, Valuation and Earnings

Last price:
$346.10
Seasonality move :
9.23%
Day range:
$349.84 - $356.57
52-week range:
$194.36 - $356.57
Dividend yield:
0%
P/E ratio:
27.04x
P/S ratio:
0.67x
P/B ratio:
2.32x
Volume:
486.5K
Avg. volume:
340.6K
1-year change:
41.54%
Market cap:
$16.6B
Revenue:
$23.4B
EPS (TTM):
$13.04

Earnings Data

Next earnings date for JLL
Feb 18
2026
Most recent earnings per share
$4.61
Beat by $0.34
(Nov 5/2025)
Consensus Estimate
$4.27
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

JLL Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 $6.1B -- -- $2.92 --
02/18/2026 Q4 $7.4B -- -- $7.29 --
11/05/2025 Q3 $6.5B $6.5B $4.61 $4.27 $0.34
08/06/2025 Q2 $6.2B $6.3B $2.32 $3.20 -$0.88
05/07/2025 Q1 $5.5B $5.7B $1.14 $2.18 -$1.04
02/19/2025 Q4 $6.7B $6.8B $4.97 $6.01 -$1.04
11/06/2024 Q3 $5.6B $5.9B $3.20 $2.74 $0.46
08/06/2024 Q2 $5.6B $5.6B $1.75 $2.42 -$0.68
05/06/2024 Q1 $4.8B $5.1B $1.37 $0.86 $0.51
02/27/2024 Q4 $5.8B $5.9B $3.57 $3.73 -$0.17
11/02/2023 Q3 -- $5.1B $1.23 -- --
08/03/2023 Q2 -- $5.1B $0.05 -- --
05/04/2023 Q1 -- $4.7B -$0.19 -- --
02/28/2023 Q4 -- $5.6B $3.62 -- --
11/02/2022 Q3 -- $5.2B $2.88 -- --
08/03/2022 Q2 -- $5.3B $3.91 -- --
05/09/2022 Q1 -- $4.8B $2.86 -- --
02/28/2022 Q4 -- $5.9B $8.16 -- --
11/03/2021 Q3 -- $4.9B $4.57 -- --
08/04/2021 Q2 -- $4.5B $3.82 -- --
05/05/2021 Q1 -- $4B $1.97 -- --
02/09/2021 Q4 -- $4.8B $4.80 -- --
11/02/2020 Q3 -- $4B $2.52 -- --
08/06/2020 Q2 -- $3.7B $0.29 -- --
05/05/2020 Q1 -- $4.1B $0.10 -- --
02/11/2020 Q4 -- $5.4B $5.23 -- --
11/05/2019 Q3 -- $4.5B $2.47 -- --
08/06/2019 Q2 -- $4.3B $2.40 -- --
05/07/2019 Q1 -- $7.5B $0.46 -- --
02/12/2019 Q4 -- $4.9B $4.37 -- --
11/06/2018 Q3 -- $4B $2.93 -- --
08/08/2018 Q2 -- $3.9B $2.35 -- --
05/08/2018 Q1 -- $3.6B $0.88 -- --
02/07/2018 Q4 -- $2.5B $1.66 -- --
11/06/2017 Q3 -- $1.9B $2.15 -- --
08/02/2017 Q2 -- $1.8B $2.06 -- --
05/05/2017 Q1 -- $1.6B $0.16 -- --
02/06/2017 Q4 -- $2.2B $3.62 -- --
11/02/2016 Q3 -- $1.7B $1.05 -- --
08/02/2016 Q2 -- $1.6B $1.73 -- --
04/27/2016 Q1 -- $1.3B $0.57 -- --

Jones Lang LaSalle, Inc. Earnings Questions

  • How Much did Jones Lang LaSalle, Inc. Generate in Revenue Last Quarter?

    Jones Lang LaSalle, Inc. reported $6.5B worth of top line sales in its most recent quarter.

  • Did Jones Lang LaSalle, Inc. Beat Earnings Last Quarter?

    Jones Lang LaSalle, Inc. announced earnings per share of $4.61 which represents a beat of analyst forecast a $4.27 per share.

  • Is Jones Lang LaSalle, Inc. Profitable?

    Jones Lang LaSalle, Inc. reported $6.5B that represents $133.46 per share over the last quarter.

  • What is the Analyst Consensus for Jones Lang LaSalle, Inc. EPS Next Year?

    Jones Lang LaSalle, Inc.'s earnings are forecast to grow from $11.30 per share to $17.37 per share next year representing an increase of 53.65%.

  • When is Jones Lang LaSalle, Inc.'s Earnings Date?

    Jones Lang LaSalle, Inc.'s next earnings date is February 18, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
70
RGC alert for Jan 8

Regencell Bioscience Holdings Ltd. [RGC] is down 21.5% over the past day.

Buy
64
RVMD alert for Jan 8

Revolution Medicines, Inc. [RVMD] is up 4.61% over the past day.

Sell
38
CRNX alert for Jan 8

Crinetics Pharmaceuticals, Inc. [CRNX] is down 0.23% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock